Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for SentinelOne

Elaine Mendonca by Elaine Mendonca
February 14, 2024
in Breaking News
0
Biotechnology Market Capitalization
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

As of February 14, 2024, SentinelOne (NYSE: S) has received various analyst ratings in the past three months. Here is a summary of the ratings:

Rating Total Ratings Last 30D 1M Ago 2M Ago 3M Ago
Bullish 4 1 1 0 2
Somewhat Bullish 4 0 0 0 4
Indifferent 2 0 0 1 1
Somewhat Bearish 0 0 0 0 0
Bearish 0 0 0 0 0

Analysts have also provided 12-month price targets for SentinelOne. The average target is $28.2, with a high estimate of $35.00 and a low estimate of $20.00. This indicates a 30.74% increase from the previous average price target of $21.57.

Several analysts have recently adjusted their ratings and price targets for SentinelOne. Here are the details:

– Tal Liani from B of A Securities upgraded the rating to Buy with a price target of $35.00, previously $26.50.
– Gray Powell of BTIG issued a Buy rating with a price target of $30.00.
– Fatima Boolani from Citigroup upgraded the rating to Neutral with a price target of $25.00, previously $24.00.
– Shyam Patil of Susquehanna issued a Positive rating with a price target of $35.00.
– Patrick Colville from Scotiabank upgraded the rating to Sector Perform with a price target of $20.00, previously $16.50.
– Shaul Eyal of TD Cowen upgraded the rating to Outperform with a price target of $30.00, previously $20.00.
– Adam Tindle from Raymond James upgraded the rating to Strong Buy with a price target of $26.00, previously $22.00.
– Hamza Fodderwala of Morgan Stanley upgraded the rating to Overweight with a price target of $25.00, previously $20.00.
– Trevor Walsh from JMP Securities upgraded the rating to Market Outperform with a price target of $33.00, previously $22.00.
– Alex Henderson of Needham maintained a Buy rating with a price target of $23.00.

Overall, the consensus among analysts is a Moderate Buy rating for SentinelOne. There is a mix of Buy and Hold recommendations, with no Sell ratings.

Stock of Company S Shows Interesting Price Momentum: Potential Reversal or Temporary Dip?

On February 14, 2024, the stock of company S showed interesting price momentum as it traded near the top of its 52-week range and remained above its 200-day simple moving average. According to data sourced from CNN Money, the price of S shares experienced a decline of $0.71 since the market closed on the previous day. This represents a 2.39% drop. The closing price of S shares on February 13, 2024, stood at $28.99. In pre-market trading on February 14, 2024, the stock rose by $1.69. While the price drop may raise concerns, the subsequent rise in pre-market trading suggests a potential reversal or temporary dip. Investors should closely monitor the stock’s performance throughout the day. Trading near the top of its 52-week range and remaining above its 200-day simple moving average indicates relative strength in the stock. Investors should consider conducting further research and analysis to evaluate the overall performance and prospects of company S.

S Stock Performance on February 14, 2024: Total Revenue Growth, Net Income Fluctuations, and Earnings per Share

Title: S Stock Performance on February 14, 2024: A Closer Look at the Numbers

Introduction:

On February 14, 2024, S stock experienced significant changes in its financial performance compared to the previous year and the previous quarter. By analyzing the data provided by CNN Money, we can gain insights into the company’s total revenue, net income, and earnings per share (EPS).

Total Revenue Growth:

S Corporation witnessed a remarkable surge in its total revenue over the past year. The company generated $422.18 million in total revenue, marking a substantial increase of 106.14% compared to the previous year.

Furthermore, compared to the previous quarter, S Corporation’s total revenue increased by 9.87%, reaching $164.16 million.

Net Income Fluctuations:

Despite the positive revenue growth, S Corporation faced challenges in terms of net income. Over the past year, the company reported a net income of -$378.68 million, reflecting a significant decrease of 39.68% compared to the previous year.

However, there is a silver lining as S Corporation managed to improve its net income in the most recent quarter. With a net income of -$70.30 million, the company saw a promising increase of 21.48% compared to the previous quarter.

Earnings per Share Performance:

Earnings per Share (EPS) is a crucial metric that helps investors evaluate a company’s profitability on a per-share basis. In the case of S Corporation, the EPS figures show a mixed performance.

Over the past year, the company reported an EPS of -$1.36, representing a decline of 35.98% compared to the previous year.

However, in the most recent quarter, S Corporation witnessed a positive turnaround. With an EPS of -$0.24, the company experienced a notable increase of 22.4% compared to the previous quarter.

Conclusion:

The performance of S stock on February 14, 2024, showcased both positive and negative aspects. While the company experienced significant growth in total revenue, it faced challenges in terms of net income. However, S Corporation managed to improve its profitability in the most recent quarter, indicating a potential recovery.

Investors should closely monitor S Corporation’s future financial reports to assess the sustainability of its revenue growth and profitability. By evaluating the company’s ability to maintain positive momentum and address the challenges it faces, investors can make informed decisions regarding their investments in S stock.

Tags: S
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Home Construction Trading online

Great Lakes Dredge Dock Exceeds Earnings Expectations

Collaboration Between Erasca Inc and Novartis to Advance Clinical Development of Combination Therapy for Solid Tumors and Melanoma

IT-Healthcare

Biotricitys Impressive Financial Progress and Commitment to Excellence

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com